Bard Associates’s Abbott ABT Stock Holding History

Bard Associates’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.9K	Buy	43 +19	+79%	+$1.73K	﹤0.01%	272
2026 Q1	$2.46K	Buy	+24	New	+$2.71K	﹤0.01%	266

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bard Associates's ABT Position: Q2 2026 in Review

Bard Associates increased its Abbott (ABT) stake by 79% in Q2 2026, buying an estimated $1.73K and bringing the position to 43 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Bard Associates first reported a position in ABT in Q1 2026 and has held it in 2 quarters since. 2,965 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Bard Associates held 43 shares of Abbott worth $3.9K as of Q2 2026.
Bard Associates bought 19 Abbott shares in Q2 2026, an estimated $1.73K.
Abbott made up ﹤0.01% of Bard Associates's portfolio in Q2 2026, its #272 holding.
Bard Associates first reported a position in Abbott in Q1 2026 and has held it in 2 quarters since.
2,965 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.